3Rieux-Laucat F.Inherited and acquired death receptor defects in human autoimmune lymphoproliferative syndrome.Curr Dir Autoimmun,2006,9:18-36.
4Sneller MC,Wang J,Dale JK,et al.Clincal,immunologic,and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.Blood,1997,89:1341-1348.
5Rieux-Lancat F,Blachere S,Danielan S,et al.Lymphoproliferative syndrome with autoimmunity:a possible genetic basis for dominant expression of the clinical manifestations.Blood,1999,94:2575-2582.
6Auricchio L,Vitiello L,Adriani M,et al.Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood.Dermatology,2005,210:336-340.
7Poppema S,Maggio E,van den Berg A.Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to Fas gene mutations.Leuk Lymphoma,2004,45:423-431.
8Pittoni V,Sorice M,Circella A,et al.Specificity of antinuclear and antiphospholipid antibodies in sera of patients with autoimmune lymphoproliferative disease (ALD).Clin Exp Rheumatol,2003,21:377-385.
9Lopatin U,Yao X,Williams RK,et al.Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.Blood,2001,97:3161-3170.
10van den Berg A,Tamminga R,de Jong D,et al.FAS gene mutation in a case of autoimmune lymphoproliferative syndrome type IA with accumulation of gammadelta + T cells.Am J Surg Pathol,2003,27:546-553.
